Skip to main content

ACE/ARB Therapy at Discharge for ICD implant patients with Left Ventricular Systolic Dysfunction

CBE ID
1522
1.4 Project
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

Proportion of ICD implant patients with a diagnosis of LVSD who are prescribed ACE-I or ARB therapy at discharge.

        • 1.14 Numerator

          Count of patients with ACE-I or ARB therapy prescribed at discharge.

        • 1.15 Denominator

          1) Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ACE inhibitors who do not have a contraindication to ACE inhibitors documented
          AND
          2)Count of patients with an ICD implant with moderate or severe LVSD (LVEF<40%) who are eligible for ARB therapy who do not have a contraindication to ARB therapy documented

        • Exclusions

          Discharge status of expired
          Contraindicated or blinded to both ACE inhibitors and ARB therapy

        • Most Recent Endorsement Activity - OLD
          Measure Retired and Endorsement Removed Cardiovascular Project 2015-2016
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward
          American College of Cardiology
          Steward Organization POC Email
          Steward Organization Copyright

          © 2010 American College of Cardiology Foundation All Rights Reserved